Gennex Laboratories informs about outcome of board meeting

31 May 2023 Evaluate

Gennex Laboratories has informed that the Meeting of Board of Directors, the Board Approved and considered the following items: Audited Standalone & Consolidated Financial results for the quarter ended & Year Ended March 31, 2023 and Auditor's Report on audited Standalone & Consolidated Financial Statements for the Quarter and Year ended March 31, 2023, issued on dated May 30, 2023 along with the Statement on Impact of Audit Qualification (Standalone & Consolidated) are attached – Annexure I.

The above information is a part of company’s filings submitted to BSE.

Gennex Lab Share Price

17.15 -0.33 (-1.89%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.